Medicare Advantage Value-Based Insurance Design Model

The Medicare Advantage Value-Based Insurance Design (VBID) Model is an opportunity for Medicare Advantage plans to offer supplemental benefits or reduced cost sharing to enrollees with Centers for Medicare & Medicaid Services (CMS)-specified chronic conditions, focused on the services that are of highest clinical value to them. The model tests whether this can improve health outcomes and lower expenditures for Medicare Advantage enrollees.

Select anywhere on the map below to view the interactive version MAVBID mapped
There are 13 MA and MA-PD plans from 10 parent organizations participating in the Medicare Advantage Value-Based Insurance Design (VBID) Model. (List)


Value-Based Insurance Design (VBID) generally refers to health insurers’ efforts to structure enrollee cost-sharing and other health plan design elements to encourage enrollees to consume high-value clinical services – those that have the greatest potential to positively impact on enrollee health. VBID approaches are increasingly used in the commercial market, and evidence suggests that the inclusion of clinically-nuanced VBID elements in health insurance benefit design may be an effective tool to improve the quality of care and reduce the cost of care for Medicare Advantage enrollees with chronic diseases.

Initiative Details

The VBID Model began January 1, 2017 and will run for five years. In 2017, CMS tested the model in seven states: Arizona, Indiana, Iowa, Massachusetts, Oregon, Pennsylvania, and Tennessee, and in 2018, CMS will also test the model on Alabama, Michigan, and Texas. Beginning in 2019, CMS will expand the model to fifteen more states: California, Colorado, Florida, Georgia, Hawaii, Maine, Minnesota, Montana, New Jersey, New Mexico, North Carolina, North Dakota, South Dakota, Virginia, and West Virginia.

Eligible Medicare Advantage plans in these states, upon approval from CMS, can offer varied plan benefit design for enrollees who fall into certain clinical categories identified and defined by CMS. In 2017, those categories are diabetes, congestive heart failure, chronic obstructive pulmonary disease (COPD), past stroke, hypertension, coronary artery disease, mood disorders, and combinations of these categories. Beginning in 2018, CMS will also allow benefits for enrollees with dementia and rheumatoid arthritis. Starting in 2019, CMS will allow participants to propose a methodology that either 1) identifies enrollees with different chronic conditions than those previously established by CMS or 2) modifies the existing approved CMS chronic condition category to target a broader or smaller subset of the existing chronic condition.

Changes to benefit design made through this model may reduce cost-sharing or offer additional services to targeted enrollees; however, targeted enrollees can never receive fewer benefits or have to pay higher cost-sharing than other enrollees as a result of the model. More information is available in the documents below.

For questions regarding the VBID model, please contact

How to Apply

The Application Cycle for 2019 closed on Wednesday, January 31, 2018 5:00 p.m. EST. Information on the CY 2020 Application Cycle will be available later this year.

Additional Information

Year 1 (2017) Materials

Year 2 (2018) Materials

Year 3 (2019) Materials